Thromboelastogram changes are associated with postoperative complications after cytoreductive surgery

Abstract

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is used to treat peritoneal surface malignancies. However, surgical morbidity is high, and prediction of severe postoperative complications (SPC) is limited. We hypothesized that the changes in thromboelastogram (TEG) values following CRS could be associated with SPC.

Keywords

• thromboelastogram
• hyperthermic intraperitoneal chemotherapy
• postoperative complications